BOSTON, MASSACHUSETTS, Aug. 08, 2023 (GLOBE NEWSWIRE) BIOXYTRAN, INC. (BIXT), (the "Company"), a clinical stage biotechnology company developing oral drugs to treat COVID-19 and other viral diseases, announced the
Bioxytran Names Leslie Ajayi as Interim CMO and Head of the Medical Advisory Board tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
Bioxytran, Inc. (OTCMKTS:BIXT – Get Free Report) was the recipient of a significant increase in short interest in the month of June. As of June 30th, there was short interest totalling 51,000 shares, an increase of 4,150.0% from the June 15th total of 1,200 shares. Based on an average daily volume of 268,200 shares, the […]
Bioxytran Peer-Reviewed Journal in Vaccines Contains Mechanism Capable of Targeting Future COVID-19 Mutations tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.